Zymeworks (ZYME) Current Leases (2021 - 2026)
Zymeworks' (ZYME) quarterly Current Leases came in at $3.3 million in Q1 2026, up 0.64% year-on-year from $3.3 million in Q1 2025, and down 5.53% quarter-over-quarter from $3.5 million in Q4 2025.
Zymeworks (ZYME) Current Leases (2021 - 2026) Analysis & Trends
Zymeworks has disclosed Current Leases across 6 years of filings, most recently posting $3.3 million for Q1 2026.
- Current Leases for Q1 2026 came in at $3.3 million, up 0.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (up 0.64% YoY), and the FY2025 annual result was $3.5 million, up 26.68% from the prior year.
- Current Leases came in at $3.3 million for Q1 2026 at Zymeworks, down from $3.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $4.6 million in Q3 2022 to a low of $2.7 million in Q4 2024.
- The 5-year median for Current Leases is $3.4 million (2025), against an average of $3.5 million.
- Across the five-year window, Current Leases jumped 153.59% in 2022 and sank 35.7% in 2024, its largest moves.
- Zymeworks' Current Leases stood at $3.3 million in 2022, then rose by 28.27% to $4.3 million in 2023, then plunged by 35.7% to $2.7 million in 2024, then grew by 26.68% to $3.5 million in 2025, then retreated by 5.53% to $3.3 million in 2026.
- The last three Current Leases figures came in at $3.3 million (Q1 2026), $3.5 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.28 Mn |
| Dec 31, 2025 | 3.47 Mn |
| Sep 30, 2025 | 3.40 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 3.26 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | 2.84 Mn |
| Mar 31, 2024 | 4.16 Mn |
| Dec 31, 2023 | 4.26 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 3.65 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 3.32 Mn |
| Sep 30, 2022 | 4.61 Mn |
| Dec 31, 2021 | 1.31 Mn |